CIAM
PBYI icon

Caitong International Asset Management’s Puma Biotechnology PBYI Stock Holding History

Caitong International Asset Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41 Buy
+5
New +$37 ﹤0.01% 2382
2025
Q1 		– Sell
-133
Closed -$406 – 2442
2024
Q4 		$406 Buy
+133
New +$387 ﹤0.01% 1492

Other funds holding PBYI

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Caitong International Asset Management's PBYI Position: Q2 2026 in Review

Caitong International Asset Management opened a new position in Puma Biotechnology (PBYI) in Q2 2026: 5 shares worth $41. The stake represents ﹤0.01% of the portfolio and ranks #2382 among its holdings. This is a return to the name: Caitong International Asset Management previously reported a position in PBYI as recently as Q4 2024.

Caitong International Asset Management first reported a position in PBYI in Q4 2024 and has held it in 2 quarters since. The position peaked at $406 in Q4 2024. 160 funds tracked by Wall St. Rank hold PBYI as of Q2 2026.

  • Caitong International Asset Management held 5 shares of Puma Biotechnology worth $41 as of Q2 2026.
  • Puma Biotechnology was a new Caitong International Asset Management position in Q2 2026.
  • Puma Biotechnology made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #2382 holding.
  • Caitong International Asset Management first reported a position in Puma Biotechnology in Q4 2024 and has held it in 2 quarters since.
  • Caitong International Asset Management's Puma Biotechnology position peaked at $406 in Q4 2024.
  • 160 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.